MYELOID LEUKEMIA
Clinical trials for MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients out of options
Disease control Recruiting nowThis early-stage study is testing a new oral medication called HQP1351 for patients with chronic myeloid leukemia (CML) or a type of acute lymphoblastic leukemia (Ph+ ALL) that has stopped responding to or cannot tolerate standard treatments. The main goals are to find a safe and…
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC
-
Can a workout and a pill reverse muscle loss in young cancer survivors?
Disease control Recruiting nowThis study is testing if a combination of home-based exercise training and a dietary supplement can help young people who have survived a bone marrow transplant. The goal is to rebuild lost muscle mass and improve their overall fitness and heart health. Researchers will compare t…
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New Two-Drug attack on Tough-to-Treat leukemia
Disease control Recruiting nowThis study is testing the safety and effectiveness of combining two drugs, gilteritinib and momelotinib, for adults with a specific type of acute myeloid leukemia (AML) that has a mutation called FLT3 and has come back or not responded to prior treatments. The first part of the s…
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
New hope for Tough-to-Treat leukemia: early trial tests drug combo
Disease control Recruiting nowThis early-stage study is testing whether adding the drug mitoxantrone to a standard leukemia treatment can help patients whose cancer has returned or stopped responding. It will enroll about 30 adults with a specific type of acute myeloid leukemia. The main goals are to find a s…
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Feb 23, 2026 14:53 UTC